PAHs in Dietary Supplement Ingredients: The Carcinogen Most Brands Have Never Screened For

Scan the test request forms that come through our lab and you’ll notice a consistent gap. Brands ask for heavy metals, microbial counts, potency verification, and label accuracy — sometimes all at once. But PAH screening? Maybe one in fifteen new clients thinks to request it. That’s a significant blind spot for an industry that depends on heat-processed botanicals, marine-derived oils, and activated charcoal as everyday raw materials.

Polycyclic aromatic hydrocarbons are a family of more than 100 compounds formed when organic material burns incompletely or undergoes high-heat processing. The most studied member of the class — benzo[a]pyrene — carries an IARC Group 1 designation: a known human carcinogen. And yet, for dietary supplements sold in the US, there is no FDA action level, no federal maximum residue limit, and no industry-wide testing expectation. Brands are largely setting their own rules. Most haven’t set any.

How PAHs End Up in Supplement Ingredients

PAHs don’t appear randomly. They form through predictable chemistry — the incomplete combustion and pyrolysis of carbon-containing materials at elevated temperatures. Once formed, they’re lipophilic: they bind tightly to fats and accumulate in fatty tissues over time. That fat-seeking behavior explains why certain ingredient categories carry disproportionate risk.

Marine-sourced ingredients. Fish and krill bioaccumulate PAHs from contaminated ocean sediment throughout their lives. By the time anchovies or sardines are rendered into a fish oil concentrate, that PAH burden has been compressed into the lipid fraction. Deep-ocean species from remote fisheries generally carry lower loads than coastal fish from industrialized zones, but even “clean” sources merit baseline verification before you put a purity claim on the label.

Activated charcoal supplements. This is where brands are consistently surprised. Activated charcoal — the ingredient marketed for detox support, teeth whitening, and GI applications — is manufactured by heating organic source material (typically coconut shells, wood, or bituminous coal) to 600–900°C, then activating it with steam or chemical agents. PAHs are a direct byproduct of that high-temperature carbonization step. The activation process removes a portion of the PAHs formed during charring, but not all. The residual burden depends heavily on the source material and process conditions.

Smoke-dried and kiln-dried botanicals. Traditional herbal drying methods in parts of Asia, Eastern Europe, and South America involve direct exposure to combustion smoke or high-temperature kilns without controlled airflow. Valerian root, dong quai, saw palmetto, and several traditional Chinese medicinal herbs are among the materials we’ve seen flagged when brands actually request PAH screening. Processing parameters vary widely by region and producer, which is precisely what makes supplier qualification for these materials non-negotiable.

Resins, mineral pitches, and dark extracts. Shilajit — the Himalayan mineral pitch that’s gained significant traction in men’s health and adaptogen products — carries a documented PAH contamination risk alongside its well-known heavy metal burden. Propolis and certain dark plant resins can similarly absorb environmental PAHs from contaminated harvesting environments or nearby industrial activity. The darker and more resinous the material, the more surface area exists for lipophilic contaminant uptake.

What GC-MS Testing for PAHs Actually Involves

PAH analysis is a gas chromatography-mass spectrometry application. Sample preparation begins with solvent extraction — typically acetonitrile or n-hexane, depending on whether the matrix is botanical or lipid-rich — followed by cleanup steps to remove co-extractants that would otherwise obscure the chromatographic separation.

For high-fat matrices like fish oil or krill oil, we add a saponification step before extraction. Saponification hydrolyzes the triglycerides, liberating PAH molecules from the lipid matrix and making them accessible to the extraction solvent. This step isn’t optional if you want accurate results. Skip it and you’ll systematically underreport PAH concentrations in any oil-based sample — a meaningful problem when you’re trying to interpret results against a regulatory threshold.

We typically run the 16 EPA priority PAHs, then provide focused interpretation around the four compounds the EU uses for food supplement compliance: benzo[a]pyrene (BaP), benz[a]anthracene, benzo[b]fluoranthene, and chrysene — collectively called PAH4.

Detection limits for BaP in botanical matrices run below 0.5 μg/kg under standard GC-MS conditions. In lipid matrices with proper saponification prep, modern GC-MS/MS instrumentation achieves 0.1 μg/kg or better. That level of sensitivity is necessary for interpreting results against California Prop 65 exposure thresholds, where fractions of a microgram determine whether a warning label is required.

One practical note brands should understand upfront: PAH analysis requires dedicated instrumentation and its own sample preparation workflow. It’s not bundled into your standard heavy metals panel or your microbial testing package. It’s a separate method requiring separate scheduling — but the turnaround time is typically five to seven business days, which is compatible with most incoming QC timelines.

The Regulatory Gap — and Where Liability Actually Lives

The US regulatory picture for PAHs in dietary supplements is honest to describe in one sentence: there isn’t one. The FDA has issued PAH guidance for seafood consumed following oil spill events, and the EPA regulates 16 priority PAHs aggressively in environmental and occupational settings. For supplement ingredients specifically, there is no federal specification.

But “no specification” doesn’t mean “no liability.” Three overlapping frameworks create real exposure for US supplement brands:

California Proposition 65. OEHHA lists 15 PAHs as known carcinogens under Prop 65, including benzo[a]pyrene, benz[a]anthracene, and chrysene. For BaP, the No Significant Risk Level is 0.061 μg per day — a threshold calibrated to represent a one-in-100,000 lifetime cancer risk. At a standard two-capsule daily serving of a fish oil supplement, even modest BaP contamination in the raw oil — say, 5 μg/kg — can translate to daily consumer exposure that requires a Prop 65 warning. Most brands selling into California have no idea where they stand because they’ve never run the math against actual test data.

FDA’s adulteration authority. Under 21 CFR § 402, a food product (dietary supplements are regulated as foods) is adulterated if it bears or contains any added substance that “may render it injurious to health.” FDA hasn’t specifically invoked this provision for PAHs in supplements to date, but the authority exists. A documented product category with systematically elevated PAH levels — combined with a manufacturer that has never screened — presents a credible enforcement target if the agency chooses to focus there.

The EU standard as a practical benchmark. Commission Regulation (EU) No 835/2011 sets specific PAH limits for food supplements: BaP capped at 10 μg/kg and PAH4 at 40 μg/kg in products based on dried botanical material. These limits are increasingly adopted as voluntary internal specifications by US brands that export to European markets or source ingredients from EU-regulated suppliers. They’re sensible, scientifically grounded limits — and aligning with them gives brands a defensible internal standard even in the absence of a US equivalent.

The trajectory of US regulation is worth noting. EFSA has published comprehensive PAH risk assessments that FDA toxicologists reference regularly. The EU limits weren’t set arbitrarily; they reflect careful dose-response modeling. It would be surprising if FDA did not eventually move toward establishing supplement-specific PAH limits. Brands that have already established testing programs and internal specs will adapt easily. Those that haven’t will face a compliance scramble.

Building a Practical PAH Testing Program

Brands that have never tested for PAHs don’t need to launch a comprehensive monthly surveillance program. A structured baseline is the right starting point.

Step one: identify your highest-risk raw materials. For most supplement brands, that’s fish oil, activated charcoal, or the primary botanical in your top-selling product. Commission PAH testing on those materials from your current supplier — current, not a historical archived sample.

Step two: interpret results against two benchmarks. Compare against EU food supplement limits (BaP ≤ 10 μg/kg, PAH4 ≤ 40 μg/kg), and separately calculate daily consumer exposure relative to the Prop 65 NSRL for BaP at 0.061 μg/day. Those two data points tell you whether you have an actionable problem and which regulatory framework is most pressing.

Step three: act on the data. If results are clean, establish a written internal specification aligned with EU limits and fold PAH testing into your incoming raw material program at whatever frequency reflects your supply chain risk — annually for established suppliers is typical, per-lot for new ones.

If results are elevated, your options are reformulation with a different sourced ingredient, tightened supplier qualification requirements, or accurate evaluation of your Prop 65 disclosure obligations. What isn’t an option is continuing to sell without knowing.

The cost of a PAH baseline for three raw materials runs a few hundred dollars in lab fees. A Prop 65 enforcement action — which any private plaintiff can initiate, not just state agencies — starts at $2,500 per day per violation before legal fees. The math really isn’t complicated.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• Method Validation and Regulatory Documentation for Consumer Products — Aurora TIC provides FDA regulatory consulting, including analytical method validation frameworks that underpin supplement and ingredient compliance programs.
• Raw Material Supplier Qualification and Contaminant Screening — Ayah Labs specializes in global B2B raw material testing, helping brands evaluate botanical and ingredient suppliers with rigorous contaminant verification.